You have no items in your shopping cart.
RecombinantNANOG-TAT,Human [orb1494788]> 95% by SDS-PAGE and HPLC analyses.
36.2 kDa, analyzed by reducing SDS-PAGE.
Escherichia coli.
100 μg, 20 μg- RecombinantMIP-5/CCL15(92aa),Human [orb1494789]
> 95% by SDS-PAGE analysis.
10.2 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
5 μg, 25 μg, 1 mg - RecombinantMIP-3α/CCL20,Human [orb1494790]
> 95% as analyzed by SDS-PAGE.
8.0 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
5 μg, 25 μg, 1 mg - RecombinantMIP-2/CXCL2,Mouse [orb1494791]
> 95% as analyzed by SDS-PAGE.
8.0 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
5 μg, 25 μg, 1 mg - RecombinantMIP-1β/CCL4,Human [orb1494792]
> 95% as analyzed by SDS-PAGE and HPLC.
7.6 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
5 μg, 25 μg, 1 mg - RecombinantMIP-1α/CCL3,Human [orb1494793]
> 95% as analyzed by SDS-PAGE and HPLC.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantM-CSF,Rat [orb1494796]
> 95% as analyzed by SDS-PAGE.
28 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantM-CSF,Mouse [orb1494797]
> 95% as analyzed by SDS-PAGE.
30 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg - RecombinantM-CSF,Human [orb1494798]
> 95% as analyzed by non-reducing SDS-PAGE.
28 kDa, observed by non-reducing SDS-PAGE.
Escherichia coli.
10 μg, 100 μg, 1 mg - RecombinantFGF-basic(145aa),Human [orb1494868]
> 95% as analyzed by SDS-PAGE.
16.4 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg